Orange Book product · Generic (ANDA)
CEFADROXIL
CEFADROXIL/CEFADROXIL HEMIHYDRATE
At a glance
Apr 25, 2013
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 25, 2013
13 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Strength
EQ 250MG BASE/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 065349
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFADROXIL/CEFADROXIL HEMIHYDRATE
- —DURICEFBrand (NDA)
NDA 050512 · WARNER CHILCOTT
- —DURICEFBrand (NDA)
NDA 050527 · WARNER CHILCOTT
- —DURICEFBrand (NDA)
NDA 050528 · WARNER CHILCOTT
- 2017CEFADROXILGeneric (ANDA)
ANDA 205072 · CSPC OUYI
- 2012CEFADROXILGeneric (ANDA)
ANDA 091036 · HIKMA PHARMS
- 2008CEFADROXILGeneric (ANDA)
ANDA 065396 · LUPIN
- 2007CEFADROXILGeneric (ANDA)
ANDA 065392 · LUPIN
- 2007CEFADROXILGeneric (ANDA)
ANDA 065352 · AUROBINDO PHARMA
- 2006CEFADROXILGeneric (ANDA)
ANDA 065307 · CHARTWELL RX
- 2006CEFADROXILGeneric (ANDA)
ANDA 065309 · CHARTWELL RX
- 2006CEFADROXILGeneric (ANDA)
ANDA 065301 · CHARTWELL RX
- 2006CEFADROXILGeneric (ANDA)
ANDA 065260 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
